Adipic Acid

Adipic Acid

SCHEMBL23780659

N.O=C(O)CCCCC(=O)O.[Cu]

nearest known ligand 0.85

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC18A2SLC6A2SLC6A3

The experimentally established mechanism targets of Adipic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.85
TSHR P16473 5/20 0.79
NFKB1 P19838 2/20 0.79
PMP22 Q01453 1/20 0.79
SLC22A6 Q4U2R8 2/20 0.71
GPR84 Q9NQS5 5/20 0.61
FFAR1 O14842 2/20 0.61
FFAR4 Q5NUL3 2/20 0.61
AKR1B1 P15121 1/20 0.61
CYP2D6 P10635 1/20 0.61
FOLH1 Q04609 1/20 0.61
CAMK2A Q9UQM7 1/20 0.59
PPARG P37231 6/20 0.58
PPARD Q03181 6/20 0.58
PPARA Q07869 6/20 0.58
HDAC11 Q96DB2 5/20 0.58
ALDH1A1 P00352 2/20 0.58
TLR2 O60603 2/20 0.58
TDP1 Q9NUW8 2/20 0.58
FABP4 P15090 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Adipic Acid SCHEMBL415307 0.96 LMNA (0.92) LMNATSHRNFKB1PMP22SLC22A6
Adipic Acid SCHEMBL150420 0.96 LMNA (0.92) LMNATSHRNFKB1PMP22SLC22A6
Adipic Acid SCHEMBL150419 0.96 LMNA (0.92) LMNATSHRNFKB1PMP22SLC22A6
Adipic Acid SCHEMBL11670852 0.96 LMNA (0.92) LMNATSHRNFKB1PMP22SLC22A6
Adipic Acid SCHEMBL11670143 0.96 LMNA (0.92) LMNATSHRNFKB1PMP22SLC22A6
Adipic Acid SCHEMBL810932 0.96 LMNA (0.92) LMNATSHRNFKB1PMP22SLC22A6
Adipic Acid SCHEMBL2586414 0.96 LMNA (0.92) LMNATSHRNFKB1PMP22SLC22A6
Adipic Acid SCHEMBL14856387 0.92 LMNA (0.85) LMNATSHRNFKB1PMP22SLC22A6
Ammonia Solution, Strong SCHEMBL2593810 0.92 TSHR (0.92) LMNATSHRNFKB1PMP22SLC22A6
Ammonia Solution, Strong SCHEMBL1351583 0.92 TSHR (0.92) LMNATSHRNFKB1PMP22SLC22A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12043721-B2 Antiviral/antimicrobial polymer compositions, fibers, and products ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) 2024-07-23 US claimed
CN-116171192-A Filter media construction 奥升德功能材料运营有限公司 2023-05-26 CN claimed
WO-2022040578-A1 FILTER MEDIA STRUCTURES ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) 2022-02-24 WO claimed
US-20220054964-A1 FILTER MEDIA STRUCTURES ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) 2022-02-24 US claimed
US-12534299-B2 Antimicrobial/antiviral conveyor belt ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) 2026-01-27 US disclosed
EP-4677144-A1 FIBERS AND FABRICS WITH NITROGEN-CONTAINING ADDITIVES Ascend Performance Materials Operations LLC (US) 2026-01-14 EP disclosed
US-12383851-B2 Filters and facemasks having antimicrobial or antiviral properties ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) 2025-08-12 US disclosed
EP-4562233-A1 BICOMPONENT FABRICS WITH SHORT FIBERS Ascend Performance Materials Operations LLC (US) 2025-06-04 EP disclosed
CN-119998505-A Bicomponent fabric with staple fibers 奥升德功能材料运营有限公司 2025-05-13 CN disclosed
WO-2025096564-A1 ANTIMICROBIAL/ANTIVIRAL BRUSHES ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) 2025-05-08 WO disclosed
WO-2025080546-A1 SPUNLACE WITH STABLE CONSTRUCTION AND WICKING PERFORMANCE ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) 2025-04-17 WO disclosed
EP-4522799-A1 ALKALI-TREATED FABRICS/FIBERS/STAPLES WITH IMPROVED ANTIMICROBIAL PROPERTIES Ascend Performance Materials Operations LLC (US) 2025-03-19 EP disclosed
WO-2021216540-A1 FILTERS AND FACEMASKS HAVING ANTIMICROBIAL OR ANTIVIRAL PROPERTIES ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) 2021-10-28 WO disclosed
US-20210322908-A1 FILTERS AND FACEMASKS HAVING ANTIMICROBIAL OR ANTIVIRAL PROPERTIES ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) 2021-10-21 US disclosed
WO-2021178681-A1 ANTIVIRAL ARTICLES ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) 2021-09-10 WO disclosed
WO-2021178673-A1 ANTIVIRAL/ANTIMICROBIAL POLYMER COMPOSITIONS, FIBERS, AND PRODUCTS ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) 2021-09-10 WO disclosed
WO-2021178677-A1 ANTIMICROBIAL/ANTIVIRAL PLASTICS AND MOLDED PRODUCTS ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) 2021-09-10 WO disclosed
US-20210277203-A1 ANTIMICROBIAL/ANTIVIRAL PLASTICS AND MOLDED PRODUCTS ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) 2021-09-09 US disclosed
US-20210277234-A1 ANTIVIRAL/ANTIMICROBIAL POLYMER COMPOSITIONS, FIBERS, AND PRODUCTS ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) 2021-09-09 US disclosed
US-20210274778-A1 ANTIVIRAL ARTICLES ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) 2021-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12534299-B2 Antimicrobial/antiviral conveyor belt POLR1C, SLC30A6, ATP6V0C LMNA 3381/4885TSHR 3939/4885NFKB1 1617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.